The Candida albicans agglutinin-like sequence (ALS) family encodes large cell surface glycoproteins that function in adhesion of the fungus to host and abiotic surfaces. Monoclonal antibodies (mAbs) specific for each Als protein were developed to study Als localization on the C. albicans surface. An anti-Als4 mAb demonstrated that Als4 covers the surface of yeast cells, with a greater abundance of Als4 on cells grown at 30°C compared to 37°C. On germ tubes, Als4 is localized in a restricted area proximal to the mother yeast. Immunolabeling with several anti-Als mAbs showed overlapping localization of Als1 and Als4 on yeast cells and Als1, Als3 and Als4 on germ tubes. Overlapping localization of Als proteins was also observed on yeast and hyphae recovered from mouse models of disseminated and oral candidiasis. Differences between Als localization in vivo and in vitro suggested changes in regulation of Als production in the host compared to the culture flask. Characterization with the anti-Als mAbs reveals the simultaneous presence and differences in relative abundance of Als proteins, creating an accurate image of Als representation and localization that can be used to guide conclusions regarding individual and collective Als protein function.
Introduction
Candida albicans is a commensal fungus of humans. It is isolated frequently from the oral mucosa, gastrointestinal and genital tracts of normally healthy individuals. However, C. albicans can overgrow its niche and cause disease when the normal microbiota is altered, or in cases of immune compromise. The close association between C. albicans and its host is mediated in part by fungal factors, some of which are encoded by gene families (Jones et al., 2004) . One example is the agglutinin-like sequence (Als) family of large cell surface glycoproteins (reviewed by Hoyer et al., 2008) . In C. albicans, there are eight different genetic loci encoding Als proteins. ALS genes have a similar organization. Each has a relatively conserved 5′ domain that encodes a peptide-binding site (Salgado et al., 2011) , a central domain that consists of head-to-tail copies of repeated sequence units, and a 3′ domain of relatively variable length and sequence. Mature Als proteins are glycosylated heavily and localized in the C. albicans cell wall. Als protein function is discussed most commonly in the context of adhesion to host and abiotic surfaces (reviewed in Hoyer et al., 2008) .
The presence of the ALS gene family raised many possibilities regarding the functional relationship between the Als proteins. For example, it was unknown whether one or more Als proteins are found at the same time on the surface of a C. albicans cell. It was also unknown whether each Als protein is found in a similar relative abundance or whether some are more plentiful than others. Finally, it was also unclear whether the Als proteins are represented evenly over the cell surface or have a specialized localization. The answers to these questions provide clues about the individual and collective function of the Als proteins. Study of ALS gene expression patterns provided some initial insight into these relationships. Analysis of C. albicans cells from disease models and human clinical specimens showed that transcription of all ALS genes could be detected, but that genes differed with respect to maximal expression levels (reviewed in Hoyer et al., 2008) . Some genes could reach high transcriptional levels, while others were always relatively quiet. In cultured C. albicans cells, transcription of some ALS genes was affected by stage of culture growth and/or cellular morphology. Detecting simultaneous transcription of many ALS genes argued against the idea that a single Als protein is found on the C. albicans surface at a time.
To further explore these ideas, as well as to determine the arrangement of Als proteins on individual cells in a population, efforts shifted toward raising a monoclonal antibody (mAb) specific for each Als protein. Consistent with the strong transcriptional activity of ALS3 in cultures of C. albicans germ tubes and hyphae (Hoyer et al., 1998b; Argimon et al., 2007) , anti-Als3 immunolabeling showed an intense coating of protein on the cell surface (Beucher et al., 2009; Coleman et al., 2009) . This coating was also found on hyphae isolated from a murine model of disseminated candidiasis (Coleman et al., 2009) . AntiAls3 immunolabeling on yeast cells was not detectable, consistent with the low ALS3 transcriptional activity in this morphological form. In contrast, anti-Als1 immunolabeled both yeast and germ tubes/hyphae (Coleman et al., 2010) . ALS1 transcription rises sharply as yeast cells from a saturated culture are placed into fresh medium, whether the cells are destined to grow as yeast or germ tubes. For yeast cultures, the inoculum cells become coated with Als1, except in the bud scar. The Als1 signal weakens on the surface of cells from subsequent generations until the protein becomes undetectable by immunolabeling. Because Als1 is stable on the yeast cell surface, the culture population is quite heterogeneous with respect to Als1 presence. On germ tubes in culture, Als1 is localized proximal to the mother yeast and persists as long hyphae form. In cells recovered from a mouse model of disseminated candidiasis, Als1 is found over a much more extensive area of the hypha surface compared to cultured cells (Coleman et al., 2010) .
To further these studies of Als protein localization, we developed a mAb specific for Als4. Here, we describe the mAb and use it to characterize the protein's localization on cultured C. albicans cells of various morphologies and on fungal cells recovered from animal models of candidiasis.
Materials and methods

Production of mAbs
The method for producing Als-specific mAbs was described by Coleman et al. (2009 Coleman et al. ( , 2010 and is summarized here for convenience. mAbs were raised against Pichia pastoris-produced, hexa-His-tagged fragments from the N-terminal domain of Als4 (including 329 amino acids; Coleman et al., 2009) . Briefly, the Als4 fragment was secreted into the culture supernatant, cleaving the secretory signal sequence, then purified by His-Trap column chromatography according to the manufacturer's instructions (GE Healthcare). The protein was analyzed by mass spectrometry to verify its predicted molecular mass, and visualized by SDS-PAGE and silver staining to confirm the presence of a single protein band. The Als4 N-terminal domain fragment was used to immunize BALB/c mice, and splenic lymphocytes were used to raise monoclonal antibodies. ELISA of hybridoma culture supernatant was used for initial antibody specificity testing. Positive clones were identified by their absorbance readings above background values. Typical results showed an absorbance reading of approximately 0.3 for the reaction between the anti-Als4 supernatant and its corresponding immunogen with background values 0.1. Purification of the mAb from the culture supernatant and reanalysis by ELISA typically produced absorbance readings of approximately 1.5 with background of 0.1. A mAb specific for Als4 (called 4-A1) was isotyped using the monoclonal antibody isotyping kit (Pierce) and was IgG1 with a kappa light chain. mAbantigen-binding kinetics were measured on a Biacore 3000 surface plasmon resonance system using an indirect capture method, as described previously (Coleman et al., 2009) . Surface plasmon resonance was used to measure binding kinetics between the anti-Als4 mAb and its immunogen. Replicate experiments showed a dissociation constant (K d ) of 0.8 and 0.9 nM (mean = 0.85 nM).
Candida strains
Many of the C. albicans strains used in this work were derived from SC5314 (Gillum et al., 1984) , such as CAI4 (iro1-Dura3::imm434/iro1-Dura3::imm434; Fonzi & Irwin, 1993) and CAI12, which is a CAI4 derivative (ura3/ URA3; Porta et al., 1999) . Strain 2034 (als4D/als4D; Zhao et al., 2005) was constructed from CAI4. Reintegration of the small ALS4 allele from strain SC5314 into a Ura − derivative of 2034 generated strain 2093 . Overexpression of ALS4 was accomplished using plasmid 1105 (Green et al., 2005) , which is a modified version of CIp10 (Murad et al., 2000) . Plasmid 1105 encodes the C. albicans TPI1 promoter and terminator sequences, separated by a polylinker that includes the restriction sites (5′-3′) XhoI-SmaI-NotI-BglII. The XhoI-BglII sites allow cloning for overexpression of any full-length ALS gene owing to lack of these restriction sites in any of the ALS gene-coding regions. The smaller allele of ALS4 from strain SC5314 was amplified by PCR using primers ALS4Xho (5′ CCC CTC GAG ATG CTT TTA CAA TTT TTG TTG CTA AGC 3′) and ALS2/4Bgl (5′ CCC AGA TCT TCA CTA AAA GAA TAT AGA AAT AGC AGT AAG TAA CAC ATA C 3′) and Pfu polymerase according to manufacturer's instructions. The XhoI-BglII-digested fragment was ligated into XhoI-BglII-cut plasmid 1105. The PTPI1-ALS4 overexpression construct was linearized with StuI and transformed into C. albicans strain CAI4. Southern blotting demonstrated that the construct integrated into the RP10 locus of CAI4.
Candida albicans strains of diverse origin and clade assignment (detailed in Coleman et al., 2009) were also used. These included strains WO-1, GC15, GC23, 1-28, 2309, SqF087, CrA038 and OKP77. A set of diverse Candida species was assembled including Candida dubliniensis strains CD36 (from Derek Sullivan, Trinity College, Dublin, Ireland), CM1 and 16F (from Richard Barton, University of Leeds, UK), as well as isolates purchased from the American Type Culture Collection (Candida glabrata ATCC 2001, Candida krusei ATCC 14243, Candida parapsilosis ATCC 22109, Candida lusitaniae ATCC 42720, Candida tropicalis ATCC 201380 and Candida guilliermondii ATCC 6260).
Candida albicans culture conditions
Routine culture used yeast extract-peptone-dextrose (YPD) liquid or agar plates (per liter: 10 g yeast extract, 20 g peptone, 20 g dextrose, with 20 g Bacto agar added for plates).
Isolates were stored at À80°C and streaked to YPD agar for use. Plates were incubated at 37°C for 24 h and stored for no more than 1 week at 4°C. A single colony was added to 20 mL YPD liquid for each starter culture. Starter cultures were incubated for 16 h and 200 r.p.m. shaking. Experiments that required 37°C used cells from a 37°C starter culture; for 30°C experiments, a 30°C starter culture was used. Starter culture cells were washed in Dulbecco's PBS without calcium or magnesium (DPBS), counted and inoculated at 1 9 10 6 cells mL À1 into the appropriate growth medium for the experiment. For germ tube growth, cells were inoculated into prewarmed (37°C) germ tube-inducing growth medium at a density of 5 9 10 6 cells mL
À1
. Media included RPMI 1640 without L-glutamine, YPD with 10% fetal bovine serum, DPBS with 10% fetal bovine serum and the medium described by Lee et al. (1975) . Additional cell culture details accompany individual experiments in the Results as appropriate.
Covalent and immunolabeling of the C. albicans cell surface Anti-Als immunolabeling methods have been described previously (Coleman et al., 2009 (Coleman et al., , 2010 . For routine immunolabeling, C. albicans cells were fixed in DPBS containing 3% paraformaldehyde. Fixed cells were washed in DPBS and nonspecific binding blocked with normal goat serum. Cells were incubated with anti-Als mAb and then with a secondary FITC-conjugated antibody. Fluorescence was detected by microscopy, using one of two different microscope systems. The first was an Olympus BX50 FluoView confocal microscope using Melles Griot argon (488 nm) and krypton (568 nm) lasers. The second was a Zeiss Axiovert 200M microscope equipped with a mercury X-Cite illuminator, an ApoTome Structured Illumination Optical Sectioning system with a VH ApoTome grid under a weak ApoTome filter setting, standard excitation and emission filters for FITC and rhodamine, a Plan-Apochromat 963/ 1.40 numerical aperture oil objective lens, and an AxioCam Mrc 5 color camera. Methods for electron microscopy detection of immunogold labeling were described previously (Coleman et al., 2009) .
Identification of the inoculum cells in a culture was accomplished by covalent labeling of the C. albicans cell surface with Alexa 594 carboxylic acid, succinimidyl ester (Molecular Probes A-20004) as described previously (Coleman et al., 2010) . Alexa dyes were also used for direct labeling of mAbs for multicolor imaging of Als proteins on the C. albicans cell surface. Anti-Als1 and anti-Als3 mAbs were labeled with Alexa 633 (Molecular Probes A20170) and Alexa 594 (Molecular Probes A10239), respectively, according to manufacturer's instructions. Candida albicans germ tubes were grown at 37°C for 1 h in RPMI 1640 medium and then fixed in DPBS with 3% paraformaldehyde. Germ tubes were washed in DPBS, then labeled with anti-Als4, followed by a FITC-conjugated secondary antibody as described earlier. Following washing, the germ tubes were incubated with 0.018 mg mL À1 Alexa 633-conjugated anti-Als1 and Alexa 594-conjugated anti-Als3 in DPBS for 1 h at 4°C. Germ tubes were washed three times in DPBS and suspended in 50 µl DPBS. Ten microliters of the cell suspension was mixed with ProLong Gold antifade reagent (Molecular Probes P36930) in a 1 : 1 ratio, placed on a glass slide, coverslipped and allowed to set for 24 h. Slides were examined using the Zeiss Axiovert 200M microscope (described above). Overlapping Als protein localization on C. albicans euthanized 28 h postinoculation and C. albicans analyzed in homogenized kidney tissue. Background information for the mouse model of oral candidiasis was taken from the Candida literature (Kamai et al., 2001; de Repentigny et al., 2002; Clancy et al., 2009; Conti et al., 2009 ) and assembled into the method presented here. Six-week-old male C57BL/6J mice (approximately 21 g; Jackson Laboratories) were immunosuppressed with 225 mg kg À1 cortisone acetate (Sigma) in saline with 0.1%
Murine models of candidiasis
Tween 80 (Sigma) administered on days À1, +1 and +3 relative to the day of inoculation with C. albicans. On day À1, mice were anesthetized with isoflurane administered in an induction chamber and a sterile swab used to sample the oral cavity. Plating of the swab on Sabouraud dextrose agar (per liter: 20 g glucose, 10 g Bacto peptone, 17 g Bacto agar, pH 6.9) with 20 µg mL À1 chloramphenicol (SDA + Cml) was used to ensure that the mouse was free of C. albicans prior to the start of the experiment. A calcium alginate urethral swab soaked in a suspension of C. albicans yeasts (1 9 10 8 cells mL
À1
) was used to inoculate the oral cavity. Mice were anesthetized with an intraperitoneal injection of 200 mg kg À1 ketamine, placed on a heating pad, and the C. albicans-soaked swab placed sublingually for 60 min. Mice were housed individually and provided food and water ad libitum. Infection proceeded for 24 h or for 5 days. At each time point, mice were sedated with isofluorane and euthanized with an intraperitoneal injection of Fatal Plus (Vortech). The mouse head was sagittally sectioned from ventral to dorsal along the midline splitting the mandibular symphysis and mandibular and maxillary incisors. The right side of the head was fixed in 10% neutral buffered formalin (pH 7.2) for histopathology analysis. The oral mucosa was dissected from the left side of the head to evaluate CFU g À1 of tissue. The left half of the tongue was also included in this sample. To isolate the oral mucosa, a feline periosteal elevator was used to free the palatal mucosa and gingiva from the underlying bone. The pharyngeal, buccal, and labial mucosa were harvested using a combination of blunt and sharp dissection with a feline periosteal elevator and tenotomy scissors. The tissue sample was homogenized in 0.5 mL sterile saline and a portion plated onto SDA + Cml. Plates were incubated for 24 h and colonies counted manually. The remainder of the homogenate was passed over a 100-μm nylon cell strainer (BD Falcon 352360) placed on the top of a 50-mL conical tube. DPBS (50 mL) was passed through the strainer to wash free C. albicans cells and smaller tissue debris into the conical tube. The tube was centrifuged to pellet the C. albicans cells. The pellet was washed twice with sterile DPBS and then fixed in 3% paraformaldehyde. After 10 min, the suspension was washed twice with DPBS and stored at 4°C until immunolabeled.
Results and discussion
Anti-Als4 immunolabeling of C. albicans budding yeasts
Anti-Als4 specificity was initially demonstrated using ELISA and surface plasmon resonance assays. The mAb selected from these processes was called anti-Als4 4-A1. Its specificity was demonstrated further in the context of analyzing the localization of Als4 on the surface of C. albicans yeast cells (Fig. 1) . Growth conditions for the yeasts were selected based on previous transcriptional data that showed growth-stage dependence of ALS4 expression in yeast cultures with the strongest expression observed in cells from saturated cultures (Hoyer et al., 1998a; Zhao et al., 2005) . Yeast cells placed into fresh growth medium initially have abundant ALS4 mRNA. By mid-log phase of a growth curve, ALS4 mRNA is not detectable by Northern blot. ALS4 transcription increases in cultures as they reach saturation. Previous studies also showed a temperature-dependence for ALS4 expression with transcripts present at nearly 1000-fold higher copy number at 30°C compared to 37°C . Consistent with these predictions from transcriptional data, immunolabeling of CAI12 cells from a 16-h culture showed a strong surface-localized signal for 30°C-grown cells and a barely detectable signal for cells grown at 37°C (Fig. 1a and b) . Surface labeling that was observed was attributed to antigens in the outer flocculant layer of the yeast cell surface, as demonstrated by electron microscopy (Fig. 2) . Immunolabeling of cells from strain 2034 (als4D/als4D) was not detectable (Fig. 1c) . Reintegration of a wild-type ALS4 allele (strain 2093) did not restore cell surface immunolabeling (Fig. 1d) . This result was unexpected, given the previous phenotypic characterization of strain 2093 . Deletion of ALS4 results in a strain that has reduced adhesion to monolayers of vascular endothelial cells; the reduction in adhesion just crosses the threshold of statistical significance. Reintegration of a wild-type copy of ALS4 restores the wild-type phenotype . Real-time PCR measurements of transcript levels showed that strain 2093 has a fold change of 0.24 ± 0.14 compared with the CAI12 control, consistent with replacement of only one copy of the gene in the mutant isolate . The ALS4 allele reintegrated to create strain 2093 is the shorter of the two ALS4 alleles from C. albicans strain SC5314. In SC5314, ALS4 alleles differ by the number of copies of a 108-bp tandemly repeated sequence in the central domain of the coding region. In SC5314, one ALS4 allele has 36 copies of the repeated sequence, while the other allele only has 18 copies (Braun et al., 2005) . It is possible that the shorter allele makes a protein for which the N-terminal domain is not sufficiently surfaceexposed to be recognized by the anti-Als4 mAb.
To explore whether surface-exposed Als4 can be produced by the shorter ALS4 allele, an ALS4 overexpression strain was constructed. This strain, called 1963, expresses the shorter ALS4 allele from strain SC5314 constitutively under control of the highly active promoter from the gene encoding the glycolytic enzyme triose phosphate isomerase (TPI1). Strain 1963 has the PTPI1-ALS4 construct integrated at the RP10 locus and also two intact wild-type ALS4 alleles. To distinguish between Als4 produced from the wild-type alleles and Als4 produced from transcripts originating from the PTPI1-ALS4 construct, yeast cells were grown over a time course. Time points studied were those where most wild-type C. albicans cells do not have anti-Als4 surface labeling. Immunolabeling analyses showed that most cells of strain CAI12 were Als4 negative, while cells from the PTPI1-ALS4 strain maintained a constant strong surface signal over the course of the experiment (Fig. 3) . These results suggested that the short ALS4 allele from strain SC5134 produced protein that was visible on the C. albicans cell surface and suggested that the level of protein produced by strain 2093 was below the limit of detection for this immunolabeling assay.
Recent work used an anti-Als5 mAb to address the issue of immunodetection limits of C. albicans cell surface proteins (Zhao et al., 2011) . Although ALS5 transcription is measured readily using real-time RT-PCR techniques, maximal transcription levels observed in wild-type cells are well below those for ALS1, ALS2, ALS3 and ALS4 (reviewed in Hoyer et al., 2008 ). An anti-Als5 mAb can detect Als5 on the surface of C. albicans cells overexpressing the gene; however, immunolabeling did not show a signal for wild-type cells (Zhao et al., 2011) . Real-time RT-PCR was used to quantify ALS5 transcript levels and Western blotting of cell wall extracts used to demonstrate the presence of the protein. Immunolabeling signal amplification was unable to increase the signal to a visible level, helping to define a detection limit for the immunolabeling assay.
The stability of Als4 on the yeast surface was assessed by labeling the surface of inoculum yeast cells with Alexa 594 and following the cells in culture over time. This technique was introduced for the study of anti-Als1 (Coleman et al., 2010) . Alexa 594 was covalently attached to the surface of yeast cells that had been grown in YPD at 30°C for 16 h; labeled cells were released into fresh YPD medium. Figure 4a shows consistent Alexa 594 labeling of all yeast, despite the presence of Als4-negative cells among the inoculum yeast. Analysis of immunolabeled cells at 1 h postinoculation showed buds on which Als4 presence was very weak or below the detection limit for the immunolabeling assay (data not shown). As the culture matured to 5 h (Fig. 4b ) and 8 h (Fig. 4c) , some Alexa 594-positive yeast maintained their Als4-positive signal, suggesting relative stability of Als4 on the C. albicans cell surface. The presence of increasing numbers of Alexa 594-negative/Als4-negative cells in the culture paralleled previously documented decreasing ALS4 transcript abundance as culture growth progressed (Hoyer et al., 1998a) . At 8 h, the increasing presence of Alexa 594-negative/Als4-positive cells reflected the increasing ALS4 transcriptional activity that occurs as culture growth approaches stationary phase (Hoyer et al., 1998a) . Although rare, inoculum cells were still detectable at 24 h of culture growth, although it was unclear whether the Als4 present on these cells remained from the initial inoculum time, or reflected new Als4 synthesis as the culture moved toward stationary phase (Fig. 4d) .
Like Als4, the presence of Als1 on the surface of yeast cells in a C. albicans culture varies over the course of culture growth (Coleman et al., 2010) . ALS1 transcription increases sharply when yeast cells from a saturated culture are placed into fresh growth medium and decreases steadily over the course of culture growth. As such, inoculum cells are coated heavily with Als1 and give rise to Because the native ALS4 alleles in strain CAI12 were not transcribed actively at these time points, surface Als4 in strain 1963 was derived primarily from the PTPI1-ALS4 construct and supported the conclusion that Als4 produced from the smaller ALS4 allele was detectable on the C. albicans cell surface. Cells were imaged using an Olympus BX50 FluoView microscope.
daughters that have a decreased Als1 abundance on the cell surface. As culture growth progresses, the surface of cells from subsequent generations falls below the detection limit for labeling with anti-Als1. ALS4 transcriptional pattern and protein presence suggest that ALS4 transcription initiates as yeast cells enter mid-log phase and increases as the culture reaches saturation (Hoyer et al., 1998a) . This transcriptional pattern results in differential representation of Als4 on the yeast cell surface.
Most cells from a saturated culture are Als4 positive. Placing these into fresh medium results in a sharp decrease in ALS4 transcription, and as the ALS4 transcript is degraded or diluted over subsequent cell divisions, the cell surface presence of Als4 drops below the detection limit for the immunolabeling assay (Fig. 4) . The result is a heterogeneous representation of Als proteins on the surface of cultured cells, with some cells in the population exhibiting a heavy coating of more than one Als protein.
Anti-Als4 immunolabeling of germ tubes
Anti-Als4 was also used to detect Als4 on C. albicans germ tubes (Fig. 5) . Als4 was visible as early as 20 min following inoculation of yeasts into germ tube induction medium (Fig. 5a ). On longer germ tubes, Als4 was proximal to the mother yeast, in a restricted distribution (Fig. 5b) . The Als4 signal persisted in this location over time as the culture matured into hyphae (data not shown). The growth temperature of the inoculum culture dictated whether mother yeast cells were labeled with anti-Als4. Growth of the inoculum cells at 37°C resulted in mother yeasts with barely detectable anti-Als4 signal. However, growth of the inoculum cells at 30°C gave mother yeasts with a strong Als4 presence (Fig. 5c) .
Growth of germ tubes in other germ tube induction media (YPD + 10% fetal bovine serum, DPBS + 10% fetal bovine serum, Lee medium) gave similar results (data not shown). 
Anti-Als4 immunolabeling of diverse Candida isolates
Coleman et al. (2009) described a set of diverse C. albicans isolates that were also listed in Materials and methods. The isolates were selected to represent various genetic clades and were collected from different body sites in healthy or diseased humans or animals. Yeasts were grown in YPD at 30°C until culture saturation ( ! 16 h), and germ tubes were grown in RPMI 1640 for 1 h. Each of the diverse isolates had the same immunolabeling pattern as described for CAI12 (data not shown).
Anti-Als4 immunolabeling of isolates of various Candida species was also tested. Coleman et al. (2009) described the isolate collection, and the information is summarized in Materials and methods. Three strains of C. dubliniensis, and one isolate each of C. glabrata, C. krusei, C. parapsilosis, C. lusitaniae, C. tropicalis and C. guilliermondii, were tested. All Candida species were grown for 16 h in YPD at 30°C. Cells from this culture were also transferred to RPMI for 1 h at 37°C. Many of these Candida species do not form germ tubes or hyphae, so the morphologies observed for C. albicans cells grown under these standard conditions were not necessarily present in this work. Candida tropicalis grown for 1 h in RPMI produced a positive signal with anti-Als4, suggesting that the epitope recognized by the mAb is present on this strain (Fig. 6) . The anti-Als4 signal was also present on this strain for cells grown for 16 h at 30°C in YPD (data not shown). (Fig. 7) . At this time point, ALS1 transcription has increased sharply following transfer of stationary phase cells into fresh growth medium (Coleman et al., 2010) while ALS4 transcription sharply decreases (Hoyer et al., 1998a) . The net effect is yeast cells with a solid coating of both Als4 and Als1 on the surface. Lack of anti-Als1 labeling on the bud scar was noted in previous work (Coleman et al., 2010) . A similar multiple anti-Als mAb labeling was conducted on germ tubes. Mother yeast were grown for 16 h in YPD at 37°C and released into prewarmed RPMI 1640 for 1 h. Paraformaldehyde-fixed germ tubes were immunolabeled with anti-Als4 and a FITC-conjugated secondary antibody, then with Alexa 633-labeled anti-Als1 and Alexa 593-labeled anti-Als3. Overlapping areas of Als protein localization were evident in the three-color micrograph (Fig. 8) . Overlapping localization and stability of Als proteins argues against the contention that the ALS gene family exists for the purpose of generating antigenic variation that is a mechanism of immune evasion for the fungus. To pursue these ideas beyond the culture flask, C. albicans cells recovered from animal disease models were studied. Localization of Als proteins on C. albicans isolated from animal models of candidiasis Two animal models of candidiasis were used to analyze localization of Als proteins on C. albicans cells grown in vivo. Previous work using a murine model of disseminated candidiasis showed differing localization of Als1 on hyphae, compared to results from in vitro-grown cells (Coleman et al., 2010) . Mice were inoculated intravenously with C. albicans yeast cells, and the infection was Overlapping Als protein localization on C. albicans allowed to proceed for 28 h. Mice were euthanized and the kidneys removed and homogenized. Anti-Als4 immunolabeling of the supernatant from the homogenate showed rare Als4-positive hyphae (Fig. 9) . When detectable, these cells showed Als4 over a larger surface of the hypha than observed on cells grown in culture (Fig. 5) .
Because it was difficult to locate yeast cells in the kidney homogenate, Als4 localization on yeast recovered from the animal model remained unknown. Candida albicans cells were also recovered from a murine model of oral candidiasis (Fig. 10 ). In this model, both yeasts and hyphae were visible. As C. albicans cells from an oral model had yet to be analyzed with anti-Als mAbs, mAbs against Als1, Als3 and Als4 were used. Fungal cells were collected from mice that were infected for 5 days. The mean CFU g À1 in the oral tissue of the five mice in this group was 9.3 9 10 5 . As expected, anti-Als3 labeled the entire surface of hyphae from the murine model and did not label yeast cells (Fig. 10a) . Similar to the model of disseminated candidiasis, anti-Als4-positive hyphae from the oral model were rare (Fig. 10b) . AntiAls1 labeled long stretches of the hypha surface; Als1-positive hyphae were common in the oral model ( Fig. 10b and c) . In some instances, hyphae were positive for both Als1 and Als4 (Fig. 10c) . Als4-positive and Als1-positive yeast were also easy to find. In many instances, Als1 and Als4 covered the surface of the same yeast cell ( Fig. 10d and e) , although cells with either Als1 or Als4 alone were detected. In some instances, anti-Als1 labeled the yeast cell surface, with the exception of the bud scar, although far more cells appeared to have the entire surface covered with Als1 ( Fig. 10d and e) .
These results demonstrated the overlapping localization of Als proteins in vivo, as well as the different immunolabeling patterns for C. albicans grown in culture and cells isolated following growth in vivo. Much previous work has focused on differences in gene expression between cells grown in vivo and those derived from a culture flask (reviewed by Wilson et al., 2009) ; the concept of nichespecific C. albicans gene expression is recognized widely (reviewed in Kumamoto, 2008) . The anti-Als mAbs provide a new approach to studying these concepts, by identifying the end-product of gene expression differences in a specific host context. The anti-Als mAbs are powerful tools to address these experimental questions regarding C. albicans virulence and commensalism and the limit of relevant information that can be derived from cells in a culture flask. Most applicable to the current discussion, however, is the demonstration with these mAbs that Als proteins share overlapping localizations both in vitro and in vivo, providing a more complete image of the cell surface architecture of C. albicans from the viewpoint of the Als family. This image of Als protein localization and presence can be used to guide conclusions regarding individual and collective Als protein function.
